GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes, study finds – Medical Xpress
Risk for dementia, ischemic stroke, mortality lower with GLP-1 receptor agonists in type 2 diabetes, obesity – Medical Xpress